2016, FDA, Licensing and Regulatory Compliance - Health Care Compliance Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2016

FDA

Licensing

Regulatory Compliance

SQA Regulatory Surveillance Summary | Monthly Update 2022 – July/August

SQA

OCTOBER 18, 2022

The counterfeit devices were sold online by a distributor named Healthful Plus without the required license to import, distribute, or sell medical devices in Canada. The packaging of the counterfeit kits resembles authentic (licensed) BTNX Inc. products in color and typeface and uses the BTNX Inc. device identifier “COV-19C25.”

US Department of Health and Human Services

US Department of Health and Human Services FDA COVID-19 Compliance

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

DECEMBER 29, 2023

Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. The FDA’s five reviews of teratogenic risk all came to the same conclusion.

FDA

FDA US Department of Health and Human Services COVID-19 Informed Consent

SQA Regulatory Surveillance Summary | Monthly Update 2022 – July/August

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Stay Connected